Healthcare
Ally Bridge backs $301m Luoxin Pharma take-private
Healthcare-focused PE investor Ally Bridge Group will support the HK$2.3 billion ($301 million) management-led take-private of Hong Kong-listed Shandong Luoxin Pharmacy Group.
EDBI, Philips launch Singapore health tech investment platform
Singapore’s EDBI and Philips have formally launched an Asia-focused investment platform that targets companies in digital healthcare services.
Khazanah-backed fund part exits India's Apollo Hospitals for $160m
Integrated Healthcare Holdings (IHH), which is majority-owned by Malaysian sovereign wealth fund Khazanah Nasional, has sold part of its stake in India's Apollo Hospitals for INR10.7 billion ($160 million).
Hony’s healthcare platform launches HK IPO
Hospital Corporation of China (HCC), a hospital operation group established by Hony Capital, has launched a Hong Kong IPO that would see the company raise as much as HK$500 million ($64 million).
CDC, Manipal commit $20m to India's iGenetic
Indian healthcare testing firm iGenetic Diagnostics has raised INR1.3 billion ($19.9 million) from UK-based development finance institution (DFI) CDC Group and Indian conglomerate Manipal Education & Medical Group.
China healthcare platform Anxin Doctor raises $29m
Beijing-based Anxin Doctor, a mobile app focused on pediatric and women's healthcare, has completed a RMB200 million ($29 million) Series B round of funding across two tranches.
IFC set for $60m investment in SE Asian medical player
The International Finance Corporation (IFC), the investment arm of the World Bank, has proposed a commitment of $60 million to IDS Medical Systems, a Hong Kong-based healthcare industry supplier for Southeast Asia.
CDC, Manipal launch $80m emerging markets healthcare fund
UK-based development finance institution (DFI) CDC Group has partnered with India’s Manipal Education & Medical Group for an $80 million fund targeting healthcare investments in emerging markets.
VIDEO: Judith Li, Lilly Asia Ventures
Judith Li, a partner with Lilly Asia Ventures, discusses healthcare investment opportunities in China
Singapore's mClinica raises $6.3m Series A round
US-based venture capital firm Unitus Impact has led a $6.5 million Series A funding round for Singaporean healthcare technology start-up mClinica.
Fund focus: Asian LPs back AGIC’s cross-border proposal
AGIC Capital is targeting up to three more deals in 2017 as its debut Asia-Europe fund closes at $1 billion, having received strong support from Asian LPs
HG Capital invests $23m in Chinese CRO firm
Chinese private equity firm HG Capital has led a RMB160 million ($23 million) round of funding for Beijing Nuokangda Pharmaceutical Technology, a contract research organization (CRO).
Accel leads $6m round for India's SigTuple
Accel Partners has led a $5.8 million Series A round for Indian healthcare-focused AI start-up SigTuple Technologies.
ChrysCapital set for exit in Eris Lifesciences IPO
Indian pharmaceutical company Eris Lifesciences has filed for a domestic IPO that is expected to facilitate a full exit for ChrysCapital Partners, which has been an investor since 2011.
Beyond Next Ventures leads $3.4m round for Japan's CureApp
Japan-based investor Beyond Next Ventures has led a JPY380 million ($3.4 million) round for domestic healthcare software developer CureApp.
China online pharmaceutical trading site raises $16m
Yaoshibang, a Chinese B2B pharmaceutical trading platform, has raised a RMB110 million ($16 million) Series B round co-led by Shenzhen-based Green Pine Capital Partners and Fosun Group.
Singapore's CXA raises $25m Series B round
The investment arm of Singapore's Economic Development Board (EDBI) and B Capital Group have led a $25 million Series B funding round for Singaporean health technology start-up CXA Group.
German strategic buys majority stake in ICG-backed Cura Group
German healthcare services and equipment provider Fresenius Medical Care has agreed to take control of Australia’s Cura Group, a hospital operator backed by Intermediate Capital Group (ICG).
Qiming leads $20m Series A for China biopharma developer
Qiming Venture Partners has led a $20 million Series A round of funding for Chinese drug developer Connect Biopharmaceuticals.
Portfolio: EQT Partners and Australia's I-Med
When EQT Partners acquired Australia-based I-Med Radiology Network, the company had spent years in the hands of different creditors. The GP had to restore confidence internally and drive long-term growth
Pakistan PE: Maturing morale
Private equity and venture capital investment activity in Pakistan remains sparse, but early movers are beginning to cut deals with a new sense of confidence as geopolitical and economic issues simmer down
India's Practo gets $55m round led by Tencent
China's Tencent Holdings has led a $55 million Series D round for Indian clinic management software and doctor search portal developer Practo.
TPG targets up to $4.5b for seventh Asia fund
TPG Capital is seeking between $4 billion and $4.5 billion for its seventh pan-Asian fund, having closed the previous vehicle at $3.3 billion in 2014 after a challenging two-year-plus process.
Abraaj invests in Pakistani diagnostics business
The Abraaj Group has invested an undisclosed sum in Islamabad Diagnostics Centre (IDC), an affordable health diagnostics provider with 20 facilities in Pakistan.